var title_f24_61_25552="Palpation lateral femoral condyle";
var content_f24_61_25552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Palpation of the lateral femoral condyle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Palpation of the lateral femoral condyle is performed to assess the integrity of the iliotibial band, a broad, thick fascia that is the distal portion of the tensor fascia lata and the vastus lateralis fascia. It crosses the prominence of the lateral femoral condyle to attach primarily at the proximal tibia and blends with the lateral patellar retinaculum near the lateral joint line. The lateral femoral condyle is palpated 1 inch above the joint line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25552=[""].join("\n");
var outline_f24_61_25552=null;
var title_f24_61_25553="Empyema gas liquid level CT";
var content_f24_61_25553=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64051&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Empyema with gas-liquid level",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Empyema with large gas-liquid level in the left posterior hemithorax due to a bronchopleural fistula. The adjacent lung is compressed and partially atelectatic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25553=[""].join("\n");
var outline_f24_61_25553=null;
var title_f24_61_25554="Patient information: Advance directives (The Basics)";
var content_f24_61_25554=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16583\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?25/23/25979\">",
"         Resources that can help you make advance directives",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/12/25795\">",
"         Patient information: Ventricular fibrillation (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Advance directives (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/advance-directives-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H2346552\">",
"      <span class=\"h1\">",
"       What are advance directives?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Advance directives are legal documents that allow you to decide now what type of medical care you would want if you ever became unable to speak for yourself. These documents can help make sure that you get the care you want even if you have an unexpected serious illness or accident. The documents can also make things easier for the people who will need to make decisions for you if you ever become unable to make them for yourself.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346569\">",
"      <span class=\"h1\">",
"       Are there different kinds of advance directives?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are many kinds of advance directives, but the 2 most useful kinds are called: &nbsp;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Healthcare proxy (also called medical power of attorney)",
"        </strong>",
"        &ndash; The healthcare proxy allows you to choose someone to make medical decisions for you if you become unable to speak for yourself. The benefit of having this document is that it makes your choice of a decision-maker clear to your doctors and family members. When you choose a healthcare proxy, it is important to talk to the person you choose about the things that you do or don&rsquo;t want. That way your decision-maker knows what to do later on if he or she ever has to speak for you.",
"       </li>",
"       <li>",
"        <strong>",
"         Living will",
"        </strong>",
"        &ndash; A living will allows you to choose now the type of care you want if you become unable to speak for yourself. For instance, a living will allows you to record in writing whether you would want a breathing tube or a feeding tube put in if you had a serious illness or accident.",
"        <br/>",
"        <br/>",
"        One specific type of living will is called a",
"        <strong>",
"         do not",
"         <span class=\"nowrap\">",
"          resuscitate/do",
"         </span>",
"         not intubate order",
"        </strong>",
"        (also called a",
"        <span class=\"nowrap\">",
"         DNR/DNI).",
"        </span>",
"        A",
"        <span class=\"nowrap\">",
"         DNR/DNI",
"        </span>",
"        is a form that tells your doctors and other members of your healthcare team that you do not want your heart restarted and you do not want a breathing tube put in if your heart stops or you stop breathing.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346586\">",
"      <span class=\"h1\">",
"       How do I choose a healthcare proxy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Choose someone who:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You know and trust",
"       </li>",
"       <li>",
"        Can separate his or her own wishes from your own",
"       </li>",
"       <li>",
"        You know would carry out your wishes if that became necessary",
"       </li>",
"       <li>",
"        Could be easily reached if he or she was needed",
"       </li>",
"       <li>",
"        Could handle it if other family members or loved ones wanted you to get treated differently than you would want",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      You will probably also need to choose an alternate proxy, in case your first choice cannot be reached at the time decisions need to be made.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346601\">",
"      <span class=\"h1\">",
"       Who should have an advance directive?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Advance directives are a good idea for anyone, but they are especially important if:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        You are older than 65.",
"       </li>",
"       <li>",
"        You have a serious life-threatening illness, such as advanced cancer, or end-stage heart or liver failure.",
"       </li>",
"       <li>",
"        The person whom you would like as your healthcare proxy (decision-maker) is not a family member or legally married to you. If that is the case the person you would choose might not be allowed to make decisions for you. Unless there is a healthcare proxy, the law usually states that a person&rsquo;s closest family member has the right to make decisions for him or her. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346616\">",
"      <span class=\"h1\">",
"       What kinds of decisions will I need to make?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your advance directives can have as much or as little detail as you want. But many people who have advance directives record their wishes about:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Breathing tubes",
"        </strong>",
"        &ndash; If you stop breathing or are having a very hard time breathing, you can get attached to a machine that will breathe for you. For that to happen, you will have a tube put in that goes down your throat and into your lungs. Then the tube will be connected to a breathing machine. When the tube is in place, you will not be able to eat. You will also not be able to talk, at least at first. Plus, you will probably be sedated, meaning that you are on medicines that make you sleep.",
"        <br/>",
"        <br/>",
"        Sometimes a breathing machine is needed only for a short time. For instance, some people need the breathing machine just while they recover from a lung infection. When deciding about a breathing tube, consider whether you&rsquo;ll be using it to get through a short-term problem that is expected to improve with treatment. But keep in mind that any time a breathing machine is used, it is hard to know for sure if and when it will be able to be disconnected.",
"       </li>",
"       <li>",
"        <strong>",
"         Cardiopulmonary resuscitation (CPR)",
"        </strong>",
"        &ndash; If your heart stops beating suddenly, doctors might be able to restart it by pumping your chest, putting in a breathing tube, giving you an electric shock (called &ldquo;defibrillation&rdquo;), and giving you special medicines. Some people recover completely after having their heart restarted. Others have permanent brain damage from a lack of blood flow to the brain; this is most likely in people who have an advanced, serious illness.",
"       </li>",
"       <li>",
"        <strong>",
"         Feeding tubes",
"        </strong>",
"        &ndash; If you become unable to eat, you can have a tube put into your stomach or intestines that can deliver nutrients. A feeding tube can keep a person&rsquo;s body going while he or she heals and gets strong. But it can also keep a person alive for a long time even if there is no chance the person will recover.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346631\">",
"      <span class=\"h1\">",
"       Can I change my mind?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can change your mind at any time. If you sign an advance directive and you decide you want a different kind of treatment or you no longer want the healthcare proxy you chose, all you have to do is tell your doctor or nurse about your new decision. If you want to name a new healthcare proxy or want to record new wishes, you can draw up new documents.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346646\">",
"      <span class=\"h1\">",
"       How can I draw up an advance directive?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The following table lists resources that can help you learn more about making your own advance directives (",
"      <a class=\"graphic graphic_table graphicRef65799 \" href=\"UTD.htm?25/23/25979\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2346661\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/12/25795?source=see_link\">",
"       Patient information: Ventricular fibrillation (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/61/25554?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16583 Version 5.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-ACA0B7D5D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25554=[""].join("\n");
var outline_f24_61_25554=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346552\">",
"      What are advance directives?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346569\">",
"      Are there different kinds of advance directives?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346586\">",
"      How do I choose a healthcare proxy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346601\">",
"      Who should have an advance directive?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346616\">",
"      What kinds of decisions will I need to make?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346631\">",
"      Can I change my mind?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346646\">",
"      How can I draw up an advance directive?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2346661\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16583\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/23/25979\">",
"      Resources that can help you make advance directives",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/12/25795?source=related_link\">",
"      Patient information: Ventricular fibrillation (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_61_25555="Innominate artery stenosis";
var content_f24_61_25555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F54708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F54708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 570px\">",
"   <div class=\"ttl\">",
"    Innominate artery stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 550px; height: 250px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The arteriogram demonstrates a stenosis of the proximal innominate artery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25555=[""].join("\n");
var outline_f24_61_25555=null;
var title_f24_61_25556="Right colectomy";
var content_f24_61_25556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F70995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F70995&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right colectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 529px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure illustrates the extent of a standard right colectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25556=[""].join("\n");
var outline_f24_61_25556=null;
var title_f24_61_25557="Pertuzumab: Drug information";
var content_f24_61_25557=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Pertuzumab: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?35/44/36548?source=see_link\">",
"    see \"Pertuzumab: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F14471959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information. For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F14476879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Perjeta&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F14448325\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent, Anti-HER2;",
"     </li>",
"     <li>",
"      Antineoplastic Agent, Monoclonal Antibody",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F14472492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Breast cancer, metastatic HER2+:",
"     </b>",
"     I.V.: Initial: 840 mg over 60 minutes followed by a maintenance dose of 420 mg over 30-60 minutes every 3 weeks until disease progression or unacceptable toxicity (in combination with trastuzumab and docetaxel) (Baselga, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Missed doses or delays:",
"     </i>",
"     If &lt;6 weeks has elapsed, administer the 420 mg maintenance dose; do not wait until the next planned dose. If &ge;6 weeks has elapsed, readminister the 840 mg initial dose (over 60 minutes), and then follow with a maintenance dose of 420 mg (over 30-60 minutes) every 3 weeks.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F14472493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F14472486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: No dosage adjustment provided in the manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F14472487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in the manufacturer&rsquo;s labeling (has not been studied).",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F14472485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose reductions are not recommended for pertuzumab; if trastuzumab is withheld, pertuzumab should also be withheld; pertuzumab and trastuzumab may be continued if docetaxel is discontinued.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Infusion-related reaction:",
"     </i>",
"     Slow or interrupt the infusion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Serious hypersensitivity:",
"     </i>",
"     Discontinue immediately",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Cardiotoxicity:",
"     </i>",
"     Left ventricular ejection fraction (LVEF) declines to &lt;40%",
"     <b>",
"      or",
"     </b>",
"     LVEF between 40% to 45% with &ge;10% absolute decrease from pretreatment values: Withhold treatment (pertuzumab and trastuzumab) for at least 3 weeks; may resume if LVEF returns to &gt;45%",
"     <b>",
"      or",
"     </b>",
"     to 40% to 45% with &lt;10% absolute decrease below pretreatment values. If after a repeat assessment within ~3 weeks, LVEF has not improved (or has declined further), consider discontinuing pertuzumab and trastuzumab (unless the benefit of treatment outweighs risks).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F14476880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Perjeta&trade;: 30 mg/mL (14 mL) [contains sucrose 120 mM/vial; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F14471961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F14472494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.V. infusion only, as a short infusion; infuse initial dose (840 mg) over 60 minutes; infuse maintenance dose (420 mg) over 30-60 minutes. Do not administer I.V. push or as a rapid bolus. Do not mix with other medications.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F14472478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with D",
"     <sup>",
"      5",
"     </sup>",
"     W; do not mix with other medications.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F14448338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of HER2-positive metastatic breast cancer (in combination with trastuzumab and docetaxel) in patients who have not received prior anti-HER2 therapy or chemotherapy to treat metastatic disease",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14471960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Pertuzumab may be confused with panitumumab, trastuzumab",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F14477677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Reactions reported in combination therapy with trastuzumab and docetaxel unless otherwise noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fatigue (38%), headache (21%), fever (19%; grades 3/4: 1%), dizziness (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (34%; grades 3/4: &lt;1%), pruritus (14%), dry skin (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Diarrhea (67%; grades 3/4: 8%), appetite decreased (29%), mucosal inflammation (28%), nausea (monotherapy 24%), stomatitis (19%), abnormal taste (18%), vomiting (monotherapy 15%), abdominal pain (monotherapy 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Neutropenia (53%; grades 3/4: 49%), anemia (23%; grades 3/4: 3%), neutropenic fever (14%; grades 3/4: 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Upper respiratory tract infection (17%; grades 3/4: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Infusion reactions (13%; grades 3/4: &lt;1%), hypersensitivity reactions (10% to 11%; grades 3/4: 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Paronychia (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Anorexia (monotherapy 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% and/or case reports with combination therapy (Limited to important or life-threatening): Alopecia, arthralgia, dyspnea, heart failure, insomnia, left ventricular ejection fraction decreased, myalgia, peripheral edema, leukopenia, peripheral neuropathy, pleural effusion, sepsis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F14472471\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F14472472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiotoxicity: Decreases in left ventricular ejection fraction (LVEF) are associated with HER2 inhibitors, including pertuzumab. Patients who received prior anthracycline therapy or chest irradiation may be at an increased risk for cardiotoxicity. In studies of pertuzumab (versus placebo) in combination with trastuzumab and docetaxel, the rate of cardiotoxicity (LVEF decline or symptomatic LV systolic dysfunction) was not increased in the pertuzumab group when compared to placebo.  However, patients with pretreatment LVEF &le;50%, CHF, LVEF decreases to &lt;50% during prior trastuzumab treatment, or conditions which could impair LV function (eg, uncontrolled hypertension, recent MI, serious arrhythmia requiring treatment, or cumulative lifetime anthracycline exposure &gt;360 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     doxorubicin or its equivalent) were excluded from studies. Assess LVEF at baseline and every 3 months during treatment. Withhold pertuzumab and trastuzumab if LVEF &lt;40%",
"     <b>",
"      or",
"     </b>",
"     40% to 45% with a 10% absolute decline from baseline; repeat LVEF assessment in ~3 weeks; discontinue if LVEF has not improved or has declined further (unless potential benefits outweigh risks).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity/infusion reaction: Infusion reactions (either during or on the day of infusion) have been associated with pertuzumab; commonly described as fever, chills, fatigue, headache, weakness, myalgia, hypersensitivity, abnormal taste or vomiting. The incidence of hypersensitivity/anaphylaxis was slightly higher in the group receiving pertuzumab (compared to placebo) in combination with trastuzumab and docetaxel. Monitor for 1 hour after the first infusion and for 30 minutes after subsequent infusions. For significant infusion reactions, interrupt or slow infusion rate; for severe infusion reactions, consider permanently discontinuing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy: May cause fetal harm if administered during pregnancy.",
"     <b>",
"      [U.S. Boxed Warning]: Pertuzumab exposure during pregnancy may result in embryo-fetal mortality and birth defects. Oligohydramnios has been observed in animal reproduction studies. Advise patients of the risks and the need for effective contraception.",
"     </b>",
"     Verify pregnancy status prior to treatment initiation. Effective contraception should be used during therapy and for 6 months after treatment. Effects during pregnancy are likely to occur in any trimester.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; HER2 expression: Establish HER2 status prior to treatment; has only been studied in patients with evidence of HER2 overexpression, either as 3+ IHC (Dako Herceptest&trade;) or FISH amplification ratio &ge;2 (Dako",
"     <i>",
"      HER",
"     </i>",
"     2 FISH pharmDx&trade; test).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F14471029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F14471027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abciximab: May enhance the potential for allergic or hypersensitivity reactions to Monoclonal Antibodies. Also may cause thrombocytopenia or diminished therapeutic effects.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F14471963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14471964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause fetal harm if administered during pregnancy.",
"     <b>",
"      [U.S. Boxed Warning]: Pertuzumab exposure during pregnancy may result in embryo-fetal mortality and birth defects. Oligohydramnios has been observed in animal reproduction studies. Advise patients of the risks and the need for effective contraception.",
"     </b>",
"     Verify pregnancy status prior to treatment initiation. Effective contraception should be used during therapy and for 6 months after treatment. Advise patients to immediately report to healthcare provider if pregnancy is suspected during treatment. Effects during pregnancy are likely to occur in all 3 trimesters. If administered during pregnancy, monitor for oligohydramnios (if oligohydramnios occurs, fetal testing is indicated). Report pregnancies exposed to pertuzumab to the Genentech Adverse Event Line (1-888-835-2555). Women exposed to pertuzumab during pregnancy are encouraged to enroll in MotHER (the Pregnancy Registry; 1-800-690-6720).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F14471965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14471966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse reactions in the nursing infant, the decision to discontinue breast-feeding or to discontinue pertuzumab should take into account the benefits of treatment to the mother; the extended half-life should be considered for decisions regarding breast-feeding after treatment is completed.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Perjeta Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     420 mg/14 mL (14 mL): $4890.79",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F14472498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     HER2 expression (either as 3+ IHC [Dako Herceptest&trade;] or FISH amplification ratio &ge;2 [Dako",
"     <i>",
"      HER",
"     </i>",
"     2 FISH pharmDx&trade; test]); pregnancy test; assess LVEF at baseline and every 3 months during treatment (more frequently for declines); monitor for infusion reaction and hypersensitivity",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F14472479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pertuzumab is a recombinant humanized monoclonal antibody which targets the extracellular human epidermal growth factor receptor 2 protein (HER2) dimerization domain. Inhibits HER2 dimerization and blocks HER downstream signaling halting cell growth and initiating apoptosis. Pertuzumab binds to a different HER2 epitope than trastuzumab so that when pertuzumab is combined with trastuzumab, a more complete inhibition of HER2 signaling occurs (Baselga, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F14472481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 5.12 L (Gianni, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Terminal: 18 days",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Agus DB, Gordon MS, Taylor C, et al, &ldquo;Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2005, 23(11):2534-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/15699478/pubmed\" id=\"15699478\" target=\"_blank\">",
"        15699478",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baselga J, Cort&eacute;s J, Kim SB, et al, &ldquo;Pertuzumab Plus Trastuzumab Plus Docetaxel for Metastatic Breast Cancer,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2012, 366(2):109-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/22149875/pubmed\" id=\"22149875\" target=\"_blank\">",
"        22149875",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baselga J, Gelmon KA, Verma S, et al, &ldquo;Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2010, 28(7):1138-44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/20124182/pubmed\" id=\"20124182\" target=\"_blank\">",
"        20124182",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baselga J and Swain SM, &ldquo;CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer,&rdquo;",
"      <i>",
"       Clin Breast Cancer",
"      </i>",
"      , 2010, 10(6):489-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/21147694/pubmed\" id=\"21147694\" target=\"_blank\">",
"        21147694",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gianni L, Llad&oacute; A, Bianchi G, et al, &ldquo;Open-Label, Phase II, Multicenter, Randomized Study of the Efficacy and Safety of Two Dose Levels of Pertuzumab, a Human Epidermal Growth Factor Receptor 2 Dimerization Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2010, 28(7):1131-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/20124183/pubmed\" id=\"20124183\" target=\"_blank\">",
"        20124183",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gianni L, Pienkowski T, Im YH, et al, &ldquo;Efficacy and Safety of Neoadjuvant Pertuzumab and Trastuzumab in Women With Locally Advanced, Inflammatory, or Early HER2-Positive Breast Cancer (Neosphere): A Randomised Multicentre, Open-Label, Phase 2 Trial,&rdquo;",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2012, 13(1):25-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/22153890/pubmed\" id=\"22153890\" target=\"_blank\">",
"        22153890",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Portera CC, Walshe JM, Rosing DR, et al, &ldquo;Cardiac Toxicity and Efficacy of Trastuzumab Combined With Pertuzumab in Patients With [Corrected] Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer,&rdquo;",
"      <i>",
"       Clin Cancer Res",
"      </i>",
"      , 2008, 14(9):2710-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25557/abstract-text/18451236/pubmed\" id=\"18451236\" target=\"_blank\">",
"        18451236",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 85639 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-BA7A5ED351-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25557=[""].join("\n");
var outline_f24_61_25557=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471959\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14476879\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14448325\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472492\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472493\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472486\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472487\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472485\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14476880\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471961\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472494\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472478\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14448338\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471960\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14477677\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472471\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472472\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471029\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471027\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471963\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471964\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471965\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471966\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570440\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472498\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472479\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472481\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85639\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/85639|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/44/36548?source=related_link\">",
"      Pertuzumab: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_61_25558="Leuprolide: Pediatric drug information";
var content_f24_61_25558=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Leuprolide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"    see \"Leuprolide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?0/48/774?source=see_link\">",
"    see \"Leuprolide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F187454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Eligard&reg;;",
"     </li>",
"     <li>",
"      Lupron Depot-Ped&reg;;",
"     </li>",
"     <li>",
"      Lupron Depot&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F187455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Eligard&reg;;",
"     </li>",
"     <li>",
"      Lupron&reg;;",
"     </li>",
"     <li>",
"      Lupron&reg; Depot&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Hormone (Gonadotropin Hormone-Releasing Analog)",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Luteinizing Hormone-Releasing Hormone Analog",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"      see \"Leuprolide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"     <b>",
"      Precocious puberty:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Initiate for girls &lt;8 years or boys &lt;9 years; consider discontinuing leuprolide therapy in girls by age 11 and boys by age 12.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lupron Depot-Ped&reg; (monthly formulation):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Manufacturer's labeling: Initial:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &le;25 kg: 7.5 mg every 4 weeks; titrate dose in 3.75 mg increments every 4 weeks until clinical or laboratory tests indicate adequate suppression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;25-37.5 kg: 11.25 mg every 4 weeks; titrate dose in 3.75 mg increments every 4 weeks until clinical or laboratory tests indicate adequate suppression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     &gt;37.5 kg: 15 mg every 4 weeks; titrate dose in 3.75 mg increments every 4 weeks until clinical or laboratory tests indicate adequate suppression",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Alternative dosing: Initial: 0.2-0.3 mg/kg/dose every 4 weeks (Carel, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lupron Depot-Ped&reg; (3-month formulation): 11.25 mg or 30 mg every 12 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ (Leuprolide acetate 5 mg/mL solution): Initial:  50",
"     <b>",
"      mcg",
"     </b>",
"     /kg/dose once daily; may titrate dose upward by 10",
"     <b>",
"      mcg",
"     </b>",
"     /kg/day if suppression of ovarian or testicular steroidogenesis is not achieved.",
"     <b>",
"      Note:",
"     </b>",
"     Higher",
"     <b>",
"      mcg",
"     </b>",
"     /kg doses may be required in younger children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Leuprolide (GNrHa) Stimulation Test (Female):",
"     </b>",
"     SubQ (Leuprolide acetate 5 mg/mL solution): 20",
"     <b>",
"      mcg",
"     </b>",
"     /kg once; measure LH and FSH at baseline and after administration (usually two spaced measurements &le;120 minutes [eg, 30 and 60 minutes",
"     <b>",
"      or",
"     </b>",
"     60 and 120 minutes]) (Houk, 2008; Sathasivam, 2010; Sathasivam, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Advanced prostate cancer:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lupron Depot&reg; 7.5 mg (monthly): 7.5 mg every month",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lupron Depot&reg; 22.5 mg (3 month): 22.5 mg every 12 weeks",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lupron Depot&reg; 30 mg (4 month): 30 mg every 16 weeks",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Lupron Depot&reg; 45 mg (6 month): 45 mg every 24 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Eligard&reg;: 7.5 mg monthly",
"     <b>",
"      or",
"     </b>",
"     22.5 mg every 3 months",
"     <b>",
"      or",
"     </b>",
"     30 mg every 4 months",
"     <b>",
"      or",
"     </b>",
"     45 mg every 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Leuprolide acetate 5 mg/mL solution: 1 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Endometriosis:",
"     </b>",
"     I.M.: Initial therapy may be with leuprolide alone or in combination with norethindrone; if retreatment for an additional 6 months is necessary, concomitant norethindrone should be used. Retreatment is not recommended for longer than one additional 6-month course.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lupron Depot&reg;: 3.75 mg every month for up to 6 months",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lupron Depot&reg;-3 month: 11.25 mg every 3 months for up to 2 doses (6 months total duration of treatment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Uterine leiomyomata (fibroids):",
"     </b>",
"     I.M. (in combination with iron):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lupron Depot&reg;: 3.75 mg every month for up to 3 months",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Lupron Depot&reg;-3 month: 11.25 mg as a single injection",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F187429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as acetate [depot formulation, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Eligard&reg;: 7.5 mg (monthly), 22.5 mg (3 month), 30 mg (4 month), 45 mg (6 month) [contains polylactide-co-glycolide; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lupron Depot-Ped&reg;: 7.5 mg (monthly), 11.25 mg (3 month), 11.25 mg (monthly), 15 mg (monthly), 30 mg (3 month) [contains polylactide-co-glycolide, polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lupron Depot&reg;: 3.75 mg (monthly), 7.5 mg (monthly), 11.25 mg (3 month), 22.5 mg (3 month), 30 mg (4 month), 45 mg (6 month) [contains polylactide-co-glycolide, polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as acetate: 5 mg/mL (2.8 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F187414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Injection (solution)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Do not administer I.V.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M. (Lupron Depot&reg;, Lupron Depot-Ped&reg;): Administer as a single injection; rotate administration site periodically. Reconstitute only with diluent provided. Upon reconstitution, a milky suspension is formed;  does not contain preservatives and should be used immediately.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Leuprolide acetate 5 mg/mL solution: Administer undiluted into areas on the arm, thigh, or abdomen; rotate injection site. If an alternate syringe from the manufacturer-provided syringe is required, insulin syringes should be used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Eligard&reg;: Vary injection site; choose site with adequate subcutaneous tissue (eg, upper or midabdomen, upper buttocks); avoid areas that may be compressed or rubbed (eg, belt or waistband)",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M.: Lupron Depot&reg;, Lupron Depot-Ped&reg;: Store at room temperature of 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Leuprolide acetate 5 mg/mL solution: Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Protect from light and store vial in carton until use. Do not freeze.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Eligard&reg;: Store at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F). Allow to reach room temperature prior to using; once mixed, must be administered within 30 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of precocious puberty (FDA approved in females ages &lt;8 years and males ages &lt;9 years); palliative treatment of advanced prostate carcinoma (FDA approved in adults); treatment of anemia caused by uterine leiomyomata (fibroids) (FDA approved in adults); management of endometriosis (FDA approved in adults); has also been used in the treatment of breast cancer, infertility, and as a gonadotropin-releasing hormone analog (GnRHa) stimulation test",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F187483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lupron Depot&reg; (1-month or 3-month formulation) may be confused with Lupron Depot-Ped&reg; (1-month or 3-month formulation)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lupron Depot-Ped&reg; is available in two formulations, a 1-month formulation and a 3-month formulation. Both formulations offer an 11.25 mg strength which may further add confusion.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F187480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Children",
"     </b>",
"     (based on 1-month and 3-month pediatric formulations combined)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Emotional lability, headache, mood altered, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Acne, rash (including erythema multiforme), seborrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Vaginal bleeding, vaginal discharge. vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site pain, injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reaction, alopecia, appetite increased, arthralgia, asthma, body odor, bradycardia, cervix disorder, constipation, depression, dysmenorrhea, dyspepsia, dysphagia, epistaxis, feminization, fever, flu-like syndrome, gingivitis, goiter, growth retarded, gynecomastia, hirsutism, hyperkinesias, hypertension, infection, leukoderma, myalgia, myopathy, nausea, nervousness, peripheral edema, personality disorder, pharyngitis, purpura, rhinitis, sexual maturity accelerated, sinusitis, skin striae, somnolence, syncope, urinary incontinence, vision decreased, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Adults:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     For prostate cancer treatment, an initial rise in serum testosterone concentrations may cause &ldquo;tumor flare&rdquo; or worsening of symptoms, including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction during the first 2 weeks. Similarly, an initial increase in estradiol levels, with a temporary worsening of symptoms, may occur in women treated with leuprolide.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Delayed release formulations:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Angina, arrhythmia, atrial fibrillation, bradycardia, CHF, deep thrombophlebitis, edema, hyper-/hypotension, palpitation, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety, confusion, delusions, dementia, depression, dizziness/vertigo, fatigue, fever, headache, insomnia, nervousness, pain, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, bruising, cellulitis, hirsutism, pruritus, rash, skin reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast tenderness/pain, bicarbonate decreased, dehydration, gynecomastia, hot flashes, hyper-/hypocholesterolemia, hyperglycemia, hyperlipidemia, hyperuricemia, hypoalbuminemia, hypoproteinemia, lactation, libido decreased, menstrual disorder, testicular atrophy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Bowel function altered, constipation, diarrhea, dysphagia, gastroenteritis/colitis, gastrointestinal hemorrhage, intestinal obstruction, nausea/vomiting, ulcer, weight gain/loss",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Balanitis, bladder spasm, dysuria, erectile dysfunction, hematuria, impotence, incontinence, nocturia, penile/testis disorder, polyuria, prostatic acid phosphatase increased/decreased, urinary disorder, urinary retention, urinary urgency, urinary tract infection, urine specific gravity increased/decreased, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia, eosinophilia, leukopenia, platelets increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Hepatomegaly, liver function tests abnormal, partial thromboplastin time increased, prothrombin time increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site burning/stinging, erythema, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, bone pain, joint disorder, myalgia, neuropathy, paralysis, paresthesia, pathologic fracture, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: BUN increased, creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, dyspnea, emphysema, epistaxis, hemoptysis, pleural effusion, pulmonary edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Immediate release formulation:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Angina, arrhythmia, CHF, ECG changes/ischemia, hypertension, MI, murmur, peripheral edema, syncope, thrombosis/phlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety, depression, dizziness/lightheadedness, headache, insomnia, fatigue, fever, nervousness, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Diabetes, gynecomastia/breast tenderness/pain, hot flashes, testicular size decreased,",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Alopecia, bruising, dermatitis, itching, lesions, pigmentation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, constipation, diarrhea, dysphagia, diarrhea, dysphagia, gastrointestinal bleeding, nausea/vomiting, peptic ulcer, rectal polyps",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Bladder spasm, dysuria, impotence, incontinence, testicular pain, urinary frequency/urgency, urinary obstruction , urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Bone pain, peripheral neuropathy, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: BUN increased, creatinine increased, hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, dyspnea, pneumonia, pulmonary embolus, pulmonary fibrosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Infection, inflammation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Children and Adults:",
"     </b>",
"     <i>",
"      Any formulations:",
"     </i>",
"     Rare but important or life-threatening: Anaphylactic/anaphylactoid reactions, asthmatic reactions, bone density decreased, coronary artery disease, diabetes; fibromyalgia-like symptoms (arthralgia/myalgia, headaches, GI distress); hemoptysis, hepatic dysfunction, hypokalemia, hypoproteinemia, injection site induration/abscess, interstitial lung disease, liver injury, MI, pelvic fibrosis, penile swelling, peripheral neuropathy, photosensitivity; pituitary apoplexy (cardiovascular collapse, mental status altered, ophthalmoplegia, sudden headache, visual changes, vomiting); prostate pain, pulmonary embolism, pulmonary infiltrate, seizure, spinal fracture/paralysis, stroke, suicidal ideation/attempt (rare), tenosynovitis-like symptoms, thrombocytopenia, transient ischemic attack, uric acid increased, WBC decreased/increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to leuprolide, gonadotropin-releasing hormone (GnRH), GnRH agonist analogs, or any component; pregnancy, breast-feeding",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with risk factors for decreased bone mineral density (BMD) (ie, chronic alcohol or tobacco use, strong family history of osteoporosis, or chronic use of medications that can impact BMD, such as corticosteroids or anticonvulsants). Use caution in patients with a history of psychiatric illness; alteration in mood, memory impairment, and depression have been associated with use. Females treated for precocious puberty may experience menses or spotting during the first 2 months of treatment; notify healthcare provider if bleeding continues after the second month. Vehicle used in depot injectable formulations (polylactide-co-glycolide microspheres) has rarely been associated with retinal artery occlusion in patients with abnormal arteriovenous anastomosis. Due to differences in release properties, combinations of dosage forms or fractions of dosage forms should not be interchanged.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1048182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     ; gonadotropin-releasing hormone (GnRH) analog treatment of rodents has shown an increased incidence of pituitary tumors. Urinary tract obstruction, bone pain, neuropathy, hematuria, or spinal cord compression may occur upon initiation of therapy. Decreased bone density has been reported when used for &ge;6 months and may not be reversible. Leuprolide may cause spontaneous abortion or fetal harm when administered to a pregnant woman. Rare cases of pituitary apoplexy (frequently secondary to pituitary adenoma) have been observed with leuprolide administration (onset from 1 hour to usually &lt;2 weeks after the first dose); may present as sudden headache, vomiting, visual or mental status changes, and infrequently cardiovascular collapse; immediate medical attention required. Seizures have been reported in patients receiving leuprolide. An increase in pubertal signs and symptoms may occur in the first 2-4 weeks of therapy due to the initial stimulatory effect of leuprolide before suppression occurs.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Leuprolide injection for subcutaneous use contains benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; avoid use of leuprolide products containing benzyl alcohol in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites. Depot injection formulations may contain polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6004203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Luteinizing Hormone-Releasing Hormone Analogs may diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F187425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F187440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pregnancy must be excluded prior to the start of treatment. Although leuprolide usually inhibits ovulation and stops menstruation, contraception is not ensured and a nonhormonal contraceptive should be used. Fetal abnormalities and increased fetal mortality have been noted in animal studies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1048191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Precocious puberty: Height, weight, bone age, Tanner staging test, GnRH testing (blood LH and FSH levels), testosterone in males and estradiol in females; closely monitor patients with prostatic carcinoma for plasma testosterone, acid phosphatase, and signs of weakness, paresthesias, and urinary tract obstruction during the first few weeks of therapy",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Continuous daily administration results in suppression of ovarian and testicular steroidogenesis due to decreased levels of LH and FSH so that puberty and the pubertal growth spurt are arrested; produces a &ldquo;medical castration&rdquo; in prostate cancer patients; inhibits pituitary gonadotropin secretion",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1048197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Serum testosterone levels first increase within 3 days of therapy, then decrease after 2-4 weeks with continued therapy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of therapeutic suppression for precocious puberty:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Leuprolide: 2-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Leuprolide depot: 1 month",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Requires parenteral administration since it is rapidly destroyed within the GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 43% to 49%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: SubQ: 94%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Not well defined",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1048189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/48/774?source=see_link\">",
"      see \"Leuprolide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Female patients should be informed that menstruation or spotting may occur for the first 2 months of therapy; notify physician if vaginal bleeding continues after 2 months of drug therapy",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Carel JC, Eugster EA, Rogol A, et al, \"Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2009, 123(4):e752-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25558/abstract-text/19332438/pubmed\" id=\"19332438\" target=\"_blank\">",
"        19332438",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kappy MS, Stuart T, and Perelman A, &ldquo;Efficacy of Leuprolide Therapy in Children With Central Precocious Puberty,&rdquo;",
"      <i>",
"       Am J Dis Child",
"      </i>",
"      , 1988, 142(10):1061-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25558/abstract-text/3140654/pubmed\" id=\"3140654\" target=\"_blank\">",
"        3140654",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lee PA and Page JG, &ldquo;Effects of Leuprolide in the Treatment of Central Precocious Puberty,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 1989, 114(2):321-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25558/abstract-text/2492599 /pubmed\" id=\"2492599 \" target=\"_blank\">",
"        2492599",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tanaka T, Niimi H, Matsuo N, et al, \"Results of Long-Term Follow-Up After Treatment of Central Precocious Puberty With Leuprorelin Acetate: Evaluation of Effectiveness of Treatment and Recovery of Gonadal Function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty,\"",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2005, 90(3):1371-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/61/25558/abstract-text/15598675/pubmed\" id=\"15598675\" target=\"_blank\">",
"        15598675",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12545 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-7BCA055868-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25558=[""].join("\n");
var outline_f24_61_25558=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187454\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187455\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048192\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048184\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187429\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187414\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048195\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048187\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048194\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187483\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187480\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048199\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048183\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048182\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299584\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6004203\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187425\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F187440\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048191\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048181\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048197\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048198\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048189\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12545\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12545|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=related_link\">",
"      Leuprolide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/48/774?source=related_link\">",
"      Leuprolide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_61_25559="Patient selection for liver transplantation";
var content_f24_61_25559=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Patient selection for liver transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Lorna M Dove, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Robert S Brown, Jr, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Paul Angulo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25559/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/61/25559/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver transplantation has emerged over the past several decades as a viable treatment option for patients with acute liver failure and end-stage liver disease. Initial progress and growth were limited by technical difficulties and an inherent learning curve in the management of patients in the post-transplantation period. Improvements in transplantation outcomes have yielded a greater treatment demand and a new challenge, organ shortage.",
"   </p>",
"   <p>",
"    Although liver transplantation has proven to be a great success in a relatively short period of development, it should not be considered as either the initial or primary treatment modality for most liver diseases. Other than in a few specific disorders, transplantation is a therapy for disease complications rather than of the primary illness.",
"   </p>",
"   <p>",
"    Transplant infrequently cures the underlying disease; recurrent liver disease after transplantation occurs in anywhere from 0 to 100 percent of patients depending upon the disease for which transplant was performed. In a patient with acute liver failure secondary to drug related injury, recurrence does not occur provided that the offending agent is avoided. However, in a patient with chronic HCV, recurrent disease is expected.",
"   </p>",
"   <p>",
"    Thus, the selection of a transplant candidate is a risk-benefit analysis, in which the inherent risks of surgery, recurrent disease, and long-term immunosuppression must be weighed against the potential benefits of transplantation. These benefits differ for each patient but include improvements in survival, prevention of long-term complications, and better health-related quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Clinical Practice Committee of the American Society of Transplantation has attempted to identify and define criteria for the non-transplant clinician on indications for and timing of solid organ transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first premise states that an early referral to a transplant center should be the standard of care. This allows patients, families, referring clinicians, and transplant centers ample time to become acquainted and identify any potential problems of undergoing a transplant. Transplant care is provided by a team including medical specialists (eg, cardiologist, hepatologist), surgeons, transplant coordinators (often nurses or nurse practitioners), a psychiatrist, and social workers. The exact composition of providers varies at different centers.",
"     </li>",
"     <li>",
"      Multiple disease processes can result in liver failure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cirrhosis (",
"      <a class=\"graphic graphic_table graphicRef67925 graphicRef74040 \" href=\"UTD.htm?11/55/12157\">",
"       table 1A-B",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef55647 \" href=\"UTD.htm?29/63/30716\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/2\">",
"       2",
"      </a>",
"      ]. Any patient with documented acute liver failure (ALF), decompensated cirrhosis, or hepatocellular carcinoma (within defined criteria) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36362?source=see_link\">",
"       \"Liver transplantation for hepatocellular carcinoma\"",
"      </a>",
"      ) is a potential candidate for liver transplantation. Although the end-result (ie, requiring a liver transplantation) is the same, differences in the underlying causes have implications for the transplant evaluation process and the expectations after transplant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Acute liver failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute liver failure is defined as the acute onset of liver failure with the development of encephalopathy in a short period of time. The etiology varies but the progression is similar in all cases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=see_link\">",
"     \"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of liver transplantation, patients with ALF will either have a complete recovery of liver function or will die, often within days [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/3\">",
"     3",
"    </a>",
"    ]. It is not always possible to predict accurately, which is the more likely outcome. As a result, early referral to a transplant center is critical to offer the best chance for a favorable outcome. Patients with ALF are given the highest priority on the transplant list (United Network of Organ Sharing [UNOS] Status 1).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cirrhosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of cirrhosis alone is not sufficient to warrant transplantation. Transplantation is generally considered when a patient has suffered from either a complication of portal hypertension or a manifestation of compromised hepatic synthetic function. Variceal hemorrhage, ascites, and encephalopathy are the primary manifestations of end-stage liver disease and as a group are designated as markers of decompensation. The onset of decompensation is associated with significantly impaired survival. The development of hepatorenal syndrome is an ominous marker that signals the need for immediate transplant evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17337?source=see_link\">",
"     \"Overview of the complications, prognosis, and management of cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All of these indications are non-specific, reflecting overall hepatic deterioration regardless of the underlying disease etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35990623\">",
"    <span class=\"h2\">",
"     Other indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain conditions that have specific indications for transplantation, such as recurrent cholangitis in patients with primary sclerosing cholangitis (PSC) or intractable pruritus in patients with primary biliary cirrhosis (PBC). Although these are not manifestations of liver failure, they are disease-specific problems that affect survival or quality of life. Hepatocellular carcinoma meeting specific criteria is another indication for liver transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36362?source=see_link&amp;anchor=H8#H8\">",
"     \"Liver transplantation for hepatocellular carcinoma\", section on 'Allocation of donor organs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uncommon indications for liver transplantation include liver metastases from neuroendocrine tumors, some forms of porphyria, and various metabolic liver diseases (eg, tyrosinemia, glycogen storage disease types I and IV). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/30/43496?source=see_link&amp;anchor=H691420#H691420\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth\", section on 'Liver transplantation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3398?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of acute intermittent porphyria\", section on 'Liver transplantation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/51/825?source=see_link&amp;anchor=H24936429#H24936429\">",
"     \"Variegate porphyria\", section on 'Refractory disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=see_link\">",
"     \"Disorders of tyrosine metabolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=see_link\">",
"     \"Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42564?source=see_link\">",
"     \"Glycogen branching enzyme deficiency (glycogen storage disease IV, Andersen disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although organ allocation is centralized, many criteria and contraindications to listing for transplantation are center-specific. The following are contraindications accepted by most centers:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiopulmonary disease that cannot be corrected and is a prohibitive risk for surgery.",
"     </li>",
"     <li>",
"      Malignancy outside of the liver within five years of evaluation (not including superficial skin cancers) or not meeting oncologic criteria for cure.",
"     </li>",
"     <li>",
"      Active alcohol and drug use. Most programs require a minimum period of abstinence of at least six months with participation in a structured rehabilitation and abstinence program and adequate social support to help maintain sobriety.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Advanced age and AIDS are examples of relative contraindications that are site-specific and are often decided on a case-by-case basis. Liver transplantation can be performed in those older than 65 provided that there has been a comprehensive search made for comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TIMING OF REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Timing of transplant referral is always a critical question. Organ allocation was initially based upon waiting time on the transplant list. As a result, early referral and listing worked to the benefit of the patient. A major problem with the system was that it did not necessarily allocate organs to patients who were at the greatest risk of dying without transplantation.",
"   </p>",
"   <p>",
"    The system was revised in 2002 to its present form where the driving force is disease severity (based mostly upon the MELD score described below) and there is no inherent benefit to early referral. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15770?source=see_link\">",
"     \"Model for End-stage Liver Disease (MELD)\"",
"    </a>",
"    .) In fact, referral too early may waste time and resources for testing that will have to be repeated when the patient has a more realistic chance of obtaining an organ. On the other hand, while early referral may not change the timing of transplantation, there continues to be a strong benefit in having the patient meet the transplant team prior to the last stages of liver disease. Often at the final stages of liver disease, there is not adequate time for education, and the patient may have an impaired mental status from underlying encephalopathy. Most centers view the prior minimum listing criteria of a Child-Pugh score of 7 (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?28/28/29121?source=see_link\">",
"     calculator 1",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?27/26/28065?source=see_link\">",
"     calculator 2",
"    </a>",
"    ) as an appropriate time for referral as it corresponds to a one-year survival without transplantation of approximately 90 percent. Others use a MELD score of 10 (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?21/23/21874?source=see_link\">",
"     calculator 3",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?18/2/18466?source=see_link\">",
"     calculator 4",
"    </a>",
"    ) or any complication of portal hypertension as markers for the need for transplant evaluation and listing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     MELD score",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are approximately 17,000 patients listed for liver transplantation in the United States, but only 5000 to 6000 transplants are performed each year [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, many patients succumb to the complications of end-stage liver disease while awaiting organ transplant.",
"   </p>",
"   <p>",
"    A great challenge has been the creation of an organ allocation system that optimizes potential outcomes and that is also fair to all potential recipients. An ideal system should select candidates based upon the potential for improving survival post transplant. Thus, being able to predict survival is crucial.",
"   </p>",
"   <p>",
"    The most commonly used prognostic model for estimating disease severity and survival is the Model for End-stage Liver Disease (MELD) (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?21/23/21874?source=see_link\">",
"     calculator 3",
"    </a>",
"    and",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?18/2/18466?source=see_link\">",
"     calculator 4",
"    </a>",
"    ). MELD has been prospectively validated in several patient populations and is currently used by the United Network for Organ Sharing (UNOS) to prioritize candidates with chronic liver failure for organ allocation. MELD has also been adopted widely by transplant programs in other countries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15770?source=see_link\">",
"     \"Model for End-stage Liver Disease (MELD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The MELD score uses a patient's laboratory values for serum bilirubin, serum creatinine, and international normalized ratio for prothrombin time (INR) in a log transformed equation to estimate likelihood of three-month survival. Higher MELD scores have been associated with decreased survival rates. Three-month survival is less than 20 percent in patients with a MELD score of 40. Implementation of MELD for organ allocation has decreased pretransplant mortality without having a negative impact on post-transplant mortality. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15770?source=see_link\">",
"     \"Model for End-stage Liver Disease (MELD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the old system, the minimal listing criterion for liver transplantation was a Child-Pugh score of 7 (",
"    <a class=\"graphic graphic_table graphicRef78401 \" href=\"UTD.htm?8/21/8540\">",
"     table 3",
"    </a>",
"    ). A MELD equivalent is likely to be approximately 10.",
"   </p>",
"   <p>",
"    The MELD score at which a patient will realistically receive a liver varies by region and organ demand as defined by the number of candidates on the waiting list and their blood type. Providers need to be aware of the average MELD at time of transplant for each blood group in their region, information that is important for determining the appropriate timing for referral.",
"   </p>",
"   <p>",
"    In addition, time on the waiting list and disease severity at transplant are associated with the volume of transplants at individual centers. Transplant centers with high volume (&ge;100 transplants per year) tend to transplant patients with lower MELD scores and have shorter waiting times than transplant centers with lower volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/6\">",
"     6",
"    </a>",
"    ]. The reasons for these differences are unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in deciding the timing of referral is to determine if there has been a complication of end-stage liver disease. This is followed by a determination of severity of illness using the MELD system. Several calculators are now readily available for calculating the MELD score (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?21/23/21874?source=see_link\">",
"     calculator 3",
"    </a>",
"    ) (",
"    <a class=\"external\" href=\"file://optn.transplant.hrsa.gov/resources/professionalresources.asp?index=8\">",
"     file://optn.transplant.hrsa.gov/resources/professionalResources.asp?index=8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Following these steps the provider can determine when transplantation referral is necessary. As a general rule, any patient with one of the defined complications of end-stage liver disease (eg, ascites, variceal bleeding, encephalopathy, hepatorenal syndrome, or hepatocellular carcinoma)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a MELD score of 10 should be referred for transplant evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PRETRANSPLANT EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of the pretransplant evaluation is to assess the ability of a patient to tolerate the stress of surgery, immunosuppression, and the demands of post-transplant care. Thus, each patient undergoes an extensive cardiopulmonary evaluation, screening for occult infection or cancer, and psychosocial evaluation (",
"    <a class=\"graphic graphic_table graphicRef60683 \" href=\"UTD.htm?1/37/1628\">",
"     table 4",
"    </a>",
"    ). Specific testing varies depending upon the patient's age, medical history, and transplant center practice. In addition, while a certain battery of tests may initiate the work up, more testing may be indicated depending upon the condition of the patient or the initial test results.",
"   </p>",
"   <p>",
"    The cardiopulmonary evaluation is designed to evaluate for significant coronary artery or valvular disease, cardiomyopathy, obstructive or restrictive lung disease, and pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Some findings discovered during initial testing may permanently preclude transplant, whereas others may need to be corrected or merely noted prior to surgery. Morbidity and mortality of liver transplantation are increased in patients with coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/10\">",
"     10",
"    </a>",
"    ] or those with severe hypoxemia and elevated mean pulmonary artery pressure measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. However, the risk of poor outcomes does not appear to be increased in patients with mild to moderate pulmonary hypertension (pulmonary artery systolic pressure between 40 and 59 mmHg) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/13\">",
"     13",
"    </a>",
"    ]. Although neither are absolute contraindications for transplant, thorough evaluation for both is crucial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40362?source=see_link&amp;anchor=H154134702#H154134702\">",
"     \"Long-term management of adult liver transplant recipients\", section on 'Cardiovascular risk'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=see_link\">",
"     \"Management of cardiac risk for noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ideal evaluation of coronary artery disease prior to liver transplantation is controversial. In 2012, The American Heart Association (AHA) and American College of Cardiology Foundation (ACCF) suggested noninvasive stress testing in liver transplantation candidates with no active cardiac conditions if there are multiple (three or more) risk factors for coronary artery disease present (eg, diabetes, prior cardiovascular disease, left ventricular hypertrophy, age greater than 60 years, smoking, hypertension, or dyslipidemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\", section on 'Established risk factors for atherosclerotic CVD'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=see_link&amp;anchor=H5#H5\">",
"     \"Stress testing for the diagnosis of coronary heart disease\", section on 'Non-invasive tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The reported sensitivity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography and myocardial perfusion scintigraphy is variable [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. The limitations of the studies in this population are presumably related to minimal coronary artery reserve, low resting systolic blood pressure, and the use of beta blockers. The current American Association for the Study of Liver Disease practice guidelines suggest that dobutamine stress echocardiography may be an effective initial screening tool [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/18\">",
"     18",
"    </a>",
"    ] but that abnormal results should be followed with angiography.",
"   </p>",
"   <p>",
"    However, because of the limitations noted above, some cardiologists recommend that in patients with known coronary artery disease, diabetes mellitus, or &gt;2 cardiovascular risk factors, coronary angiography is preferred to assess the extent and severity of coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/19\">",
"     19",
"    </a>",
"    ]. Therefore, though assessing cardiac risk is certainly crucial, ideal testing is still under investigation, and transplant centers vary in their approach. Our approach is consistent with that outlined by the",
"    <span class=\"nowrap\">",
"     AHA/ACCF",
"    </span>",
"    (ie, we obtain noninvasive stress testing in patients without active cardiac conditions who have multiple risk factors for coronary artery disease).",
"   </p>",
"   <p>",
"    Another method that is being studied for pretransplant evaluation is submaximal cardiopulmonary exercise testing. One study found that the calculated anaerobic threshold (which corresponds with cardiorespiratory reserve) predicted post-transplant mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/20\">",
"     20",
"    </a>",
"    ]. Survivors of liver transplantation had higher mean anaerobic thresholds than patients who did not survive (12.0 versus 8.4",
"    <span class=\"nowrap\">",
"     mL/min/kg).",
"    </span>",
"    This method of pretransplant evaluation is not currently in widespread use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=see_link&amp;anchor=H8#H8\">",
"     \"Functional exercise testing: Ventilatory gas analysis\", section on 'Ventilatory anaerobic threshold determination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to a standard medical evaluation, initial assessment should include an educational session discussing the risks and benefits of transplantation including the potential for poor outcomes. Thus, an evaluation of the psychological and social support of the patient is imperative. The purpose of this assessment is to identify issues that may impair a successful outcome after transplantation. These potential problems include a lack of insight into the nature of the transplant procedure and post-transplant care, and drug or alcohol dependence. The assessment includes education of the family",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    support network of the patient. The ability to comply with complex medical and behavior regimens is crucial after any organ transplant procedure. Recipients must be able to incorporate complicated medication regimens, follow-up appointments, and frequent laboratory visits into their lives. Making spouses, friends, and family aware of these requirements will encourage patient compliance and long-term success.",
"   </p>",
"   <p>",
"    In patients with a history of alcohol or drug dependence or addiction, evaluation of this illness is also crucial in preparing the patient for transplantation. The impact of drug or alcohol use after transplant is still under investigation. Recidivism can have an effect on graft function, medical compliance, and long-term survival. Thus, evaluation and treatment of drug and alcohol dependence should be addressed prior to transplant in an effort to increase the likelihood of success after transplant. The evaluation and treatment requirements for drug and alcohol dependence vary depending upon the center. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5160?source=see_link\">",
"     \"Liver transplantation in alcoholic liver disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ADULT LIVING DONOR LIVER TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adult living donor liver transplantation (LDLT) was initiated in 1998 in response to the growing shortage of organs from deceased donors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25559/abstract/21\">",
"     21",
"    </a>",
"    ]. There are small but significant risks to the donor that must be considered when contemplating the risks and benefits of LDLT versus deceased donor liver transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/4/25672?source=see_link\">",
"     \"Living donor liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most patients, receiving a whole liver may be preferable to receiving a partial graft. However, because of the organ shortage, many transplant centers do not have the ability to provide a whole liver to all patients in need of transplantation before they die. The waiting list mortality increases in patients with advanced liver disease. Thus, the main benefit of LDLT may be in decreasing wait list mortality and has been shown in experienced centers to have equivalent outcomes to whole organ deceased donor liver transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/4/25672?source=see_link\">",
"     \"Living donor liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recipients considered for LDLT should fulfill the same minimal listing criteria established for deceased donor liver transplantation. The goal is to avoid premature transplantation. The LDLT recipient candidate should undergo the same evaluation as the deceased donor recipient. The optimal MELD score at which patients undergoing LDLT derive a sustained survival benefit by reducing waiting time mortality that is not offset by post-transplant mortality is yet to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=see_link\">",
"       \"Patient information: Liver transplant (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early referral to a transplant center should be the standard of care.",
"     </li>",
"     <li>",
"      Any patient with documented acute liver failure, decompensated cirrhosis, or hepatocellular carcinoma within defined criteria is a potential candidate for liver transplantation.",
"     </li>",
"     <li>",
"      Contraindications to transplant include cardiopulmonary disease that cannot be corrected and is a prohibitive risk for surgery, malignancy outside of the liver within five years of evaluation (not including superficial skin cancers) or not meeting oncologic criteria for cure, and active alcohol or drug use.",
"     </li>",
"     <li>",
"      The first step in deciding the timing of referral is to determine if there has been a complication of end-stage liver disease. This is followed by a determination of severity of illness using the MELD score (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?21/23/21874?source=see_link\">",
"       calculator 3",
"      </a>",
"      and",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?18/2/18466?source=see_link\">",
"       calculator 4",
"      </a>",
"      ) and Child-Pugh score (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?28/28/29121?source=see_link\">",
"       calculator 1",
"      </a>",
"      and",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?27/26/28065?source=see_link\">",
"       calculator 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Any patient with one of the defined complications of end-stage liver disease (eg, ascites, variceal bleeding, encephalopathy, or hepatocellular carcinoma), a Child-Pugh score greater than 7,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a MELD score of 10 should be considered for referral to a transplant center.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/1\">",
"      Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001; 71:1189.",
"     </a>",
"    </li>",
"    <li>",
"     Zakim D, Boyer T. Hepatology A Textbook of Liver Disease, 4th ed, WB Saunders Company, Philadelphia 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/3\">",
"      Ostapowicz G, Fontana RJ, Schi&oslash;dt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/4\">",
"      Cross TJ, Antoniades CG, Muiesan P, et al. Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl 2007; 13:1382.",
"     </a>",
"    </li>",
"    <li>",
"     United Network for Organ Sharing (UNOS) Allocation of livers. Vol. 2003 www.unos.org (Accessed on October 25, 2003).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/6\">",
"      Ahmad J, Bryce CL, Cacciarelli T, Roberts MS. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med 2007; 146:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/7\">",
"      Zoghbi GJ, Patel AD, Ershadi RE, et al. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003; 92:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/8\">",
"      Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003; 37:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/9\">",
"      Guckelberger O, Mutzke F, Glanemann M, et al. Validation of cardiovascular risk scores in a liver transplant population. Liver Transpl 2006; 12:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/10\">",
"      Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/11\">",
"      Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/12\">",
"      Starkel P, Vera A, Gunson B, Mutimer D. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 2002; 8:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/13\">",
"      Harinstein ME, Iyer S, Mathier MA, et al. Role of baseline echocardiography in the preoperative management of liver transplant candidates. Am J Cardiol 2012; 110:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/14\">",
"      Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2012; 60:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/15\">",
"      Harinstein ME, Flaherty JD, Ansari AH, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008; 8:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/16\">",
"      Aydinalp A, Bal U, Atar I, et al. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc 2009; 41:3757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/17\">",
"      Oprea-Lager DE, Sorgdrager BJ, Jukema JW, et al. Clinical value of myocardial perfusion scintigraphy as a screening tool in liver transplant candidates. Liver Transpl 2011; 17:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/18\">",
"      Murray KF, Carithers RL Jr, AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005; 41:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/19\">",
"      Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol 2011; 58:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/20\">",
"      Prentis JM, Manas DM, Trenell MI, et al. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl 2012; 18:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25559/abstract/21\">",
"      Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348:818.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4585 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-AB43D6AFE1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25559=[""].join("\n");
var outline_f24_61_25559=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Acute liver failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35990623\">",
"      Other indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TIMING OF REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MELD score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PRETRANSPLANT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ADULT LIVING DONOR LIVER TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4585\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4585|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/16/24843\" title=\"table 1A\">",
"      Causes of FHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/6/23660\" title=\"table 1B\">",
"      Uncommon causes of liver TPL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/63/30716\" title=\"table 2\">",
"      Evaluation of cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/21/8540\" title=\"table 3\">",
"      Child Pugh classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/37/1628\" title=\"table 4\">",
"      Pre-liver transplant evaluation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?28/28/29121?source=related_link\" title=\"calculator 1\">",
"      Calculator: Child Pugh classification for severity of liver disease (SI units)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?27/26/28065?source=related_link\" title=\"calculator 2\">",
"      Calculator: Child Pugh classification for severity of liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?21/23/21874?source=related_link\" title=\"calculator 3\">",
"      Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?18/2/18466?source=related_link\" title=\"calculator 4\">",
"      Calculator: MELD score for end-stage liver disease (not appropriate for patients under the age of 12) (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/17/2330?source=related_link\">",
"      Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=related_link\">",
"      Disorders of tyrosine metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=related_link\">",
"      Functional exercise testing: Ventilatory gas analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/48/16136?source=related_link\">",
"      Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42564?source=related_link\">",
"      Glycogen branching enzyme deficiency (glycogen storage disease IV, Andersen disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36362?source=related_link\">",
"      Liver transplantation for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5160?source=related_link\">",
"      Liver transplantation in alcoholic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/4/25672?source=related_link\">",
"      Living donor liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/26/40362?source=related_link\">",
"      Long-term management of adult liver transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/20/3398?source=related_link\">",
"      Management of acute intermittent porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/45/29402?source=related_link\">",
"      Management of cardiac risk for noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/30/43496?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15770?source=related_link\">",
"      Model for End-stage Liver Disease (MELD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17337?source=related_link\">",
"      Overview of the complications, prognosis, and management of cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=related_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26521?source=related_link\">",
"      Stress testing for the diagnosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/51/825?source=related_link\">",
"      Variegate porphyria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_61_25560="Use of intracoronary radiation to prevent restenosis";
var content_f24_61_25560=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Use of intracoronary radiation to prevent restenosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Bruce D Klugherz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Daniel M Kolansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/61/25560/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/61/25560/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Restenosis has been the principal limitation to the long-term success of percutaneous coronary revascularization. The rate of angiographic restenosis following balloon angioplasty alone (defined as 50 percent or greater reduction in luminal diameter at follow-up angiography) is 40 to 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/1\">",
"     1",
"    </a>",
"    ]. About half of the patients with angiographic restenosis manifest clinical restenosis with recurrent ischemia that leads to repeat revascularization of the targeted vessel [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intracoronary stents, by virtue of their ability to prevent elastic recoil and constrictive remodeling, initially reduced the frequency of angiographic restenosis to approximately 20 percent and the need for repeat revascularization to approximately 10 to 12 percent (",
"    <a class=\"graphic graphic_figure graphicRef71236 \" href=\"UTD.htm?24/16/24845\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Even better results have been obtained with drug-eluting stents, which are the stents of choice for most coronary interventions (",
"    <a class=\"graphic graphic_figure graphicRef53472 \" href=\"UTD.htm?35/25/36254\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=see_link\">",
"     \"Drug-eluting intracoronary stents: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the availability of drug-eluting stents, one major focus of investigation to treat restenosis was the use of intracoronary radiation. Based upon the data presented below, the FDA has approved both gamma and beta intracoronary radiation for use the treatment of in-stent restenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/5\">",
"     5",
"    </a>",
"    ]. This technique is applied immediately after mechanical treatment of the restenosis.",
"   </p>",
"   <p>",
"    However, the increased efficacy of drug-eluting stents for in-stent restenosis has markedly limited the role of intracoronary radiation for this indication. In addition, current data do not support the use of intracoronary radiation for the prevention of restenosis of de novo lesions and the FDA has not approved this technique for this indication. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Comparison to drug-eluting stents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Another radiation approach, insertion of radioactive stents, has been demonstrated to cause an increase in restenosis at the edges of the stent and may delay rather than prevent restenosis within the stent itself. The development of these stents has been discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale of using ionizing radiation to prevent restenosis is derived from the observed benefit of radiation in reducing exuberant wound healing following surgery. In porcine models, application of endovascular radiation inhibited neointimal formation after balloon injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. These benefits may be mediated by apoptosis (programmed cell death), inhibition of the first wave of cellular proliferation, and prevention of adventitial fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiation can be delivered over the course of 3 to 30 minutes (depending upon the isotope and its activity) via percutaneously inserted catheters containing radioactive wires, balloons, ribbons, or seeds. Most studies have used gamma radiation from an Ir-192 source, which is highly penetrating in human tissue and falls off according to the inverse square law. Other studies have used shorter range beta particles from a Sr-90, P-32, or I-125 source, which have a range of only a few millimeters in tissue and yield lower whole-body dose exposure for a corresponding dose to the arterial wall. Because of this intense local absorption, beta brachytherapy can be delivered in much shorter dwell times and with much less shielding of the laboratory staff.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Radiation dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term results after radiotherapy may be influenced by the radiation dose, the homogeneity of dose distribution, the complexity of the stenotic lesion, and vessel injury at the time of radiation delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The effect of a higher beta-emitter dose was evaluated in a report of 130 patients undergoing percutaneous coronary intervention (PCI) without stenting who were randomly assigned to receive 9, 12, 15, or 18 Gy of radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/8\">",
"     8",
"    </a>",
"    ]. At six months, the restenosis rate was 28, 17, 16, and 4 percent, respectively. The rate of repeat revascularization with a dose of 9 and 18 Gy was 18 and 6 percent, respectively and there was a dose-dependent enlargement of the vessel lumen.",
"   </p>",
"   <p>",
"    Intracoronary radiation using a fixed dose of 15 Gy is less effective in longer in-stent restenotic lesions, due to greater eccentricity and variability in lesion geometry and longer source-to-target distances [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/9\">",
"     9",
"    </a>",
"    ]. However, efficacy is improved with the use of higher doses (18 Gy at 2 mm from the source) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Scattering after stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;A concern with the use of radiotherapy after stenting is the potential for absorption and scattering, especially of short-range beta particles, by stent struts that may cause significant variations in the uniformity and magnitude of the radiation dose. Stents that are made of finer struts (eg, the Wallstent, MultiLink, and NIR stents) produce minimal dose perturbations while stents that have thick",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    high density wires (eg, the Palmaz-Schatz, Wiktor, and Radius stents) produce larger inhomogeneities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the clinical significance of these differences is uncertain. As described below, trials using beta-emitters for in-stent restenosis have shown benefit that appears roughly similar to that seen in trials of more penetrating, gamma radiation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link\">",
"     \"Intracoronary stent restenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brachytherapy is effective in treating restenosis occurring after either balloon angioplasty or stenting. Some long-term data from clinical trials suggest that radiation may delay, rather than prevent, restenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Use for in-stent restenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low dose brachytherapy has been approved by the FDA as adjunctive treatment for in-stent restenosis; it appears to act by inhibiting recurrent exuberant neointimal formation within the stent, without any effect at the stent edge [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefit and clinical outcomes with intracoronary radiation are independent of the primary method used to treat in-stent restenosis (balloon angioplasty, excimer laser angioplasty, rotational atherectomy, or additional stent implantation) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. In addition, intracoronary radiation is effective in all vessel sizes, with benefit greatest in small vessel (&lt;2.5 mm) and all lesion lengths, especially in diffuse lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link\">",
"     \"Intracoronary stent restenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although both beta and gamma radiation have similar benefit in preventing recurrence of in-stent restenosis, most laboratories prefer the beta systems because of their shorter treatment times (typically 3 versus 30 minutes) and the lack of requirement for significant lead shielding to protect the operator and staff.",
"   </p>",
"   <p>",
"    A significant clinical benefit has been noted with intracoronary radiation in a number of published trials using a gamma emitter (Gamma-One, WRIST, Long WRIST) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/19-22\">",
"     19-22",
"    </a>",
"    ] or a beta emitter (INHIBIT, Beta WRIST, and START) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. The following observations illustrate the range of findings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Gamma-One trial evaluated 252 patients undergoing percutaneous therapy for in-stent stenosis in native coronary arteries; the patients were randomly assigned to a gamma emitting or nonradioactive intracoronary ribbon [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/19\">",
"       19",
"      </a>",
"      ]. At nine months, the primary end point (death, myocardial infarction, or need for target lesion revascularization) was significantly lower with intracoronary gamma radiation (28 versus 44 percent for placebo), due entirely to a reduction in target lesion revascularization.",
"     </li>",
"     <li>",
"      The WRIST trial included 130 patients with in-stent restenosis who underwent a successful PCI and were then randomly assigned to either intracoronary radiation with a gamma emitter or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/20\">",
"       20",
"      </a>",
"      ]. At six months, radiation was associated with a significant reduction in the incidence of angiographic restenosis (19 versus 58 percent for placebo), target lesion revascularization (14 versus 63 percent), and freedom from major cardiac events (29 versus 68 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At five years, the major cardiac event rate continued to be significantly lower with intracoronary radiation (46 versus 69 percent with placebo) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/14\">",
"     14",
"    </a>",
"    ]. However, in the interval between six months and five years, radiation was associated with significantly more target lesion revascularization (22 versus 5 percent), suggesting that radiation may have delayed, but not prevented, the development of restenosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Long WRIST trial demonstrated the benefit of intracoronary radiation in 240 patients with long in-stent lesions (36 to 80 mm) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/22\">",
"       22",
"      </a>",
"      ]. The first 120 patients were randomly assigned to either gamma irradiation at a dose of 15 Gy or placebo; subsequently, an additional 120 patients were treated with 18 Gy. At six months, patients assigned to high dose radiation (18 Gy), low dose radiation (15 Gy), or placebo had target lesion revascularization rates of 20, 39, and 62 percent, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The benefit of radiotherapy was more pronounced in diabetic patients in the WRIST trial and in a retrospective review of 749 patients at a single center, 43 percent of whom were diabetic [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/21\">",
"     21",
"    </a>",
"    ]. Although the outcomes were similar in nondiabetics and diabetics treated with radiation, higher rates of restenosis occurred in the diabetics in the placebo group [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=see_link\">",
"     \"Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The INHIBIT trial randomly assigned 332 patients with diffuse in-stent lesions up to 47 mm long to intracoronary beta radiation or placebo after successful PCI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/26\">",
"       26",
"      </a>",
"      ]. At nine months, radiotherapy significantly reduced the incidence of in-lesion restenosis (16 versus 48 percent for placebo), in-vessel restenosis (26 versus 52 percent), and major adverse cardiac effects (death, Q wave MI, and target lesion revascularization; 15 versus 31 percent). These relative benefits were maintained during a two year follow-up.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Comparison to drug-eluting stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two randomized trials (TAXUS V ISR and SISR) compared the efficacy of intracoronary radiation to a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5753?source=see_link\">",
"     sirolimus",
"    </a>",
"    stent in patients with in-stent restenosis that developed after prior bare metal stenting. Both had significantly better outcomes in terms of angiographic restenosis and target lesion revascularization with drug-eluting stents (6.3 versus 13.9 percent at nine months in TAXUS V ISR and 8.5 versus 19.2 percent at nine months in SISR) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. At three years, freedom from target lesion revascularization was significantly better with SES than radiation in the SISR trial (81 versus 72 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link&amp;anchor=H23#H23\">",
"     \"Intracoronary stent restenosis\", section on 'Repeat stenting in bare-metal stents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Saphenous vein grafts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of intracoronary gamma radiation as a treatment of in-stent restenosis in saphenous vein grafts was evaluated in the SVG WRIST trial of 120 patients who underwent balloon PTCA, additional stenting, or atherectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/30\">",
"     30",
"    </a>",
"    ]. At six months, the incidence of angiographic restenosis was significantly lower with intracoronary radiation (21 versus 44 percent for placebo). At 12 months, intracoronary radiation was associated with a lower rate of target lesion revascularization (17 versus 57 percent) and a lower rate of major cardiac events (32 versus 63 percent). Similar benefits were noted in another study in which intracoronary gamma radiation was as effective in saphenous vein grafts as in native artery lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26538?source=see_link\">",
"     \"Prevention, presentation, and management of saphenous vein graft stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     De novo stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of intracoronary brachytherapy was less evident in the BRIDGE study of de novo coronary lesions treated with stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/32\">",
"     32",
"    </a>",
"    ]. Of 112 patients, 54 were randomly assigned to radiation after stent placement. At six months, minimal lumen diameter was significantly greater and volume loss was significantly less with brachytherapy. However, despite efforts to optimize procedural performance, edge restenosis and late occlusions resulted in a higher rate of target vessel revascularization with radiation (20 versus 12 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Use for restenosis after PTCA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracoronary radiotherapy also appears to be effective treatment for restenosis occurring after PCI without stent placement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/13,33-35\">",
"     13,33-35",
"    </a>",
"    ]. The potential benefit was illustrated in the original SCRIPPS trial of 55 patients with a restenotic coronary artery that was a candidate for a stent (38 percent) or already contained a stent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/33\">",
"     33",
"    </a>",
"    ]. The patients were treated with PCI (balloon angioplasty and stent placement as needed) and then randomly assigned to intracoronary Ir-192 (a gamma-emitter) or placebo; angiographic restenosis at six months was much lower in the radiation group (17 versus 54 percent).",
"   </p>",
"   <p>",
"    The benefit of radiation persisted at three and five years [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/13,34\">",
"     13,34",
"    </a>",
"    ]. Target lesion revascularization was significantly less common among patients receiving intracoronary radiotherapy compared to placebo (15 versus 48 percent at three years and 23 versus 48 percent at five years). The composite end point of death, myocardial infarction, or target lesion revascularization was also significantly lower in the radiation group (23 versus 55 percent at three years and 38 versus 65 percent at five years) (",
"    <a class=\"graphic graphic_figure graphicRef68046 \" href=\"UTD.htm?25/46/26349\">",
"     figure 3",
"    </a>",
"    ). However, more late loss in minimal luminal diameter was seen in the radiation group.",
"   </p>",
"   <p>",
"    Intracoronary brachytherapy is rarely used for restenosis after PTCA in the current era.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Use after angioplasty alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are limited on the routine use of intracoronary radiation after angioplasty alone, as a prophylactic measure to prevent restenosis. This issue has become less important, since the majority of percutaneous coronary interventions currently performed include stent placement.",
"   </p>",
"   <p>",
"    Small case series and a small clinical trial, PREVENT, that was not limited to patients receiving angioplasty alone suggested a reduction in postangioplasty restenosis with intracoronary radiotherapy, using either a gamma or beta emitter [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. In contrast, a much larger study of 1455 patients with either a single de novo lesion or unstented restenosis found no significant decline in clinical restenosis with radiotherapy with a beta-emitter compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/38\">",
"     38",
"    </a>",
"    ]. Although radiotherapy reduced the incidence of angiographic restenosis within the lesion segment, it also increased restenosis at the lesion edges.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary brachytherapy appears to be relatively safe. However, a number of concerns specific to this technology have been raised. These include possible injury to angiographically normal vessels, late thrombosis, edge stenosis, delayed healing of dissections, and acute coronary spasm. In addition, restenosis remains a problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Effect on normal coronary segments",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence of any permanent deleterious effect of irradiation on angiographically normal coronary artery segments, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracoronary ultrasound performed at six months in the WRIST trial showed no effect on normal reference segments [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Late follow-up in the SCRIPPS trial showed that the rate of nontarget-vessel revascularization at five years was the same in the radiation and placebo groups [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Late thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late thrombosis, occurring more than 30 days after radiation therapy, is an infrequent complication that may be associated with myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/19,40,41\">",
"     19,40,41",
"    </a>",
"    ]. Potential causes of late thrombosis include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delayed re-endothelialization, due to the inhibition of neointima over the newly placed stents, which leaves them exposed to blood; the struts become a potential nidus for thrombosis, well beyond the two to four week time for endothelialization seen after stenting without radiation",
"     </li>",
"     <li>",
"      Fibrin deposition and enhanced platelet recruitment",
"     </li>",
"     <li>",
"      Impaired vasoreactivity and spasm",
"     </li>",
"     <li>",
"      Tissue erosion around the stent",
"     </li>",
"     <li>",
"      Unhealed dissection",
"     </li>",
"     <li>",
"      Impaired resolution of intramural hemorrhage",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The frequency with which late thrombosis occurs was assessed in a report of 473 patients who presented with in-stent restenosis and were enrolled in various radiation protocols, whether randomized to placebo versus radiation or entered into registries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/41\">",
"     41",
"    </a>",
"    ]. After a follow-up of at least six months, 9 percent presented with a late thrombotic coronary occlusion associated with a myocardial infarction, unstable angina, or no symptoms; late thrombotic occlusion was much less common (1.2 percent) in patients treated with placebo.",
"   </p>",
"   <p>",
"    With multivariate analysis, implantation of a new stent was the main predictor of late thrombotic occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/41\">",
"     41",
"    </a>",
"    ]. Similar findings were noted in the Gamma-One trial in which late thrombosis occurred in 5.3 percent of patients receiving radiation at nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/19\">",
"     19",
"    </a>",
"    ]. It was seen only in patients who had received a new stent at the time of radiation treatment and only after the discontinuation of oral antiplatelet therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/27/35255?source=see_link\">",
"     ticlopidine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Restenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted in the trials above, intracoronary radiotherapy for in-stent restenosis lowers the rate of subsequent restenosis compared to no radiotherapy. However, recurrent restenosis still occurs in 15 to 29 percent at nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/19,20,26,45\">",
"     19,20,26,45",
"    </a>",
"    ]. Delayed restenosis is also possible. In a five year follow-up from the original SCRIPPS trial, there were two occurrences of very late restenosis in the treated segment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features of late failure after intracoronary radiation were evaluated in a series of 961 patients from the WRIST trials, 282 of whom (29 percent) failed at a mean follow-up of 494 days; the failure rate was the same for beta and gamma radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/45\">",
"     45",
"    </a>",
"    ]. The main risk factor for late failure was repeat stenting. The lesions were primarily focal with a mean length of 11.9 mm. Most patients were treated with percutaneous coronary intervention (PTCA in 61 percent, restenting in 26 percent, and atherectomy in 11 percent) or, less often, bypass surgery. Although the patients responded well to revascularization, 17 percent required repeat target vessel revascularization at six months.",
"   </p>",
"   <p>",
"    A limitation to these observations is that they were made before the need for prolonged combined antiplatelet therapy, as described above, was appreciated. In addition, approximately 10 to 15 percent of failures were determined by angiography, not by symptoms or stress testing, which may have overestimated the true failure rate.",
"   </p>",
"   <p>",
"    Similar findings were noted in a smaller study of 45 patients with restenosis after intracoronary irradiation in the Gamma-One and Gamma-Two trials [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/46\">",
"     46",
"    </a>",
"    ]. Repeat PCI was acutely successful in all patients but subsequent restenosis occurred in 15 (33 percent), requiring yet another revascularization procedure, either surgical or percutaneous.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prolonged dual antiplatelet therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association of late thrombosis with a new stent and discontinuation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/27/35255?source=see_link\">",
"     ticlopidine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    led the FDA to recommend avoidance of placement of new stents when brachytherapy is used, if possible, and to continue dual antiplatelet therapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    plus clopidogrel or ticlopidine) for a minimum of six months after brachytherapy and for at least one year if a new stent is implanted [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/5\">",
"     5",
"    </a>",
"    ]. The potential efficacy of prolonged dual antiplatelet therapy has been demonstrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the WRIST PLUS trial of 120 patients with diffuse in-stent restenosis, six months of therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      was associated with the need for a new stent in 28 percent of patients and an incidence of total occlusion and late thrombosis of 5.8 and 2.5 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/47\">",
"       47",
"      </a>",
"      ]. These rates were lower than those seen with radiation therapy in the WRIST and LONG WRIST trials in which antiplatelet therapy was given for only one month and were similar to those in the placebo group in these trials.",
"     </li>",
"     <li>",
"      In the WRIST 12 trial, 120 patients with diffuse in-stent restenosis were treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      for one year; the results were compared to those in WRIST PLUS [",
"      <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/48\">",
"       48",
"      </a>",
"      ]. Although there was no difference in late thrombosis at 15 months in the two groups (3.3 and 4.2 percent), prolonged antiplatelet therapy was associated with a significant reduction in target vessel revascularization (20 versus 35 percent). Only four patients in these two studies developed late thrombosis while still taking clopidogrel.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings have led many clinicians to continue dual antiplatelet therapy for one year after intracoronary radiation therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Edge stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Edge restenosis, which was originally described with the use of radioactive stents, also occurs with intracoronary radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. In the WRIST trial, for example, the incidence of edge stenosis was 10 percent with intracoronary radiation compared to 4.7 percent with placebo after successful treatment of in-stent restenosis with PCI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of edge stenosis is enhanced by \"geographic miss\" [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/49\">",
"     49",
"    </a>",
"    ]. This term refers to failure of the radiation source to adequately cover the entire segment of artery injured during the PCI that is performed in conjunction with the radiation therapy (",
"    <a class=\"graphic graphic_figure graphicRef70164 \" href=\"UTD.htm?24/28/25028\">",
"     figure 4",
"    </a>",
"    ). Edge stenosis can be avoided by use of a radiation source at least 10 mm longer than the mechanically treated segment and careful positioning of both dilating balloons and the radiation source.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Delayed healing of dissections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild to moderate dissections are not uncommon after angioplasty, and usually resolve completely. Only limited data are available on the effect of intracoronary radiation on the healing of a dissection. One report reviewed 44 patients with postangioplasty dissections who underwent intracoronary ultrasonography at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/51\">",
"     51",
"    </a>",
"    ]. At this time, residual dissection was present in only 1 of 28 patients who did not receive intracoronary radiation compared to 7 of 16 who did (3.5 versus 44 percent). In the latter group, however, there was a significant improvement in the dissection and an increase in lumen area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link&amp;anchor=H9#H9\">",
"     \"Periprocedural complications of percutaneous coronary intervention\", section on 'Dissection and abrupt closure after PTCA'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Coronary artery spasm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal and clinical studies have demonstrated an incidence as high as 67 percent of coronary artery spasm after high-dose (24 Gy) beta irradiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/52\">",
"     52",
"    </a>",
"    ]. Spasm occurred immediately, proximal and distal to the stent, and is due to endothelial dysfunction. Although the spasm was usually minor or moderate, ECG changes or hemodynamic instability were seen in almost 30 percent of cases. Repetitive administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/24/11656?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    is an effective therapy in this situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brachytherapy using either gamma or beta radiation sources became a common treatment for in-stent restenosis prior to the availability of drug-eluting coronary stents, since it substantially reduced recurrent restenosis. It can be particularly helpful in treating long lesions, which are more subject to recurrent restenosis. The procedure has a favorable safety profile, especially if dual antiplatelet therapy is continued for an extended period (up to one year) to reduce occurrences of late thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, two randomized trials published after the 2005 guideline (TAXUS V ISR and SISR) demonstrated significantly better outcomes in terms of angiographic restenosis and target lesion revascularization with drug-eluting stents compared to intracoronary radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. As a result, drug-eluting stents should be the initial treatment of in-stent restenosis in the majority of patients. This is reflected in the 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Society",
"    </span>",
"    for Cardiovascular Angiography and Interventions Guideline for Percutaneous Coronary Intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?24/61/25560/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Comparison to drug-eluting stents'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link&amp;anchor=H23#H23\">",
"     \"Intracoronary stent restenosis\", section on 'Repeat stenting in bare-metal stents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With the use of drug-eluting stents for the treatments of in-stent restenosis in most patients, the use of brachytherapy has declined; it is available at only a very few centers. The evidence to support its use is limited.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/1\">",
"      Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988; 318:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/2\">",
"      Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 1990; 65:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/3\">",
"      Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/4\">",
"      Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/5\">",
"      Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary-artery brachytherapy. N Engl J Med 2001; 344:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/6\">",
"      Wiedermann JG, Marboe C, Amols H, et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/7\">",
"      Waksman R, Rodriguez JC, Robinson KA, et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997; 96:1944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/8\">",
"      Verin V, Popowski Y, de Bruyne B, et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001; 344:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/9\">",
"      Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound analysis of the impact of lesion length on the efficacy of intracoronary gamma-irradiation for preventing recurrent in-stent restenosis. Circulation 2001; 103:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/10\">",
"      Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma-radiation therapy for preventing recurrence in very long, diffuse, in-stent restenosis lesions. Circulation 2001; 104:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/11\">",
"      Sabat&eacute; M, Marijnissen JP, Carlier SG, et al. Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and beta-radiation therapy. Circulation 2000; 101:2472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/12\">",
"      Amols HI, Trichter F, Weinberger J. Intracoronary radiation for prevention of restenosis: dose perturbations caused by stents. Circulation 1998; 98:2024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/13\">",
"      Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation 2000; 101:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/14\">",
"      Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004; 109:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/15\">",
"      Mintz GS, Weissman NJ, Teirstein PS, et al. Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the gamma-1 study. Circulation 2000; 102:2915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/16\">",
"      Ajani AE, Waksman R, Zimarino M, et al. Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials). Am J Cardiol 2002; 89:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/17\">",
"      Park SW, Hong MK, Moon DH, et al. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon. J Am Coll Cardiol 2001; 38:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/18\">",
"      Ajani AE, Waksman R, Cha DH, et al. The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation. J Am Coll Cardiol 2002; 39:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/19\">",
"      Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/20\">",
"      Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/21\">",
"      Gruberg L, Waksman R, Ajani AE, et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002; 39:1930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/22\">",
"      Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003; 107:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/23\">",
"      Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/24\">",
"      Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000; 101:1895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/25\">",
"      Suntharalingam M, Laskey W, Lansky AJ, et al. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002; 52:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/26\">",
"      Waksman R, Ajani AE, White RL, et al. Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. Am J Cardiol 2001; 88:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/27\">",
"      Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/28\">",
"      Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006; 295:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/29\">",
"      Holmes DR Jr, Teirstein PS, Satler L, et al. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv 2008; 1:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/30\">",
"      Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002; 346:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/31\">",
"      Castagna MT, Mintz GS, Waksman R, et al. Comparative efficacy of gamma-irradiation for treatment of in-stent restenosis in saphenous vein graft versus native coronary artery in-stent restenosis: An intravascular ultrasound study. Circulation 2001; 104:3020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/32\">",
"      Serruys PW, Wijns W, Sianos G, et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol 2004; 44:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/33\">",
"      Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/34\">",
"      Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002; 105:2737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/35\">",
"      Raizner AE, Oesterle SN, Waksman R, et al. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000; 102:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/36\">",
"      King SB 3rd, Williams DO, Chougule P, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998; 97:2025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/37\">",
"      Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96:727.",
"     </a>",
"    </li>",
"    <li>",
"     Data presented at the American College of Cardiology 50th Annual Scientific Sessions 2001, Orlando, Florida.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/39\">",
"      Ahmed JM, Mintz GS, Waksman R, et al. Safety of intracoronary gamma-radiation on uninjured reference segments during the first 6 months after treatment of in-stent restenosis: a serial intravascular ultrasound study. Circulation 2000; 101:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/40\">",
"      Costa MA, Sabat&eacute; M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/41\">",
"      Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000; 36:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/42\">",
"      Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation 1999; 100:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/43\">",
"      Kay IP, Sabate M, Van Langenhove G, et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation. Heart 2000; 83:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/44\">",
"      Salame MY, Verheye S, Mulkey SP, et al. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries. Circulation 2000; 101:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/45\">",
"      Ajani AE, Waksman R, Cheneau E, et al. The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy. J Am Coll Cardiol 2003; 41:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/46\">",
"      Prpic R, Teirstein PS, Reilly JP, et al. Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. Circulation 2002; 106:2340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/47\">",
"      Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001; 103:2332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/48\">",
"      Waksman R, Ajani AE, Pinnow E, et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 2002; 106:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/49\">",
"      Kim HS, Waksman R, Cottin Y, et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/50\">",
"      Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. Am J Cardiol 2001; 87:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/51\">",
"      Meerkin D, Tardif JC, Bertrand OF, et al. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. J Am Coll Cardiol 2000; 36:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/52\">",
"      Scheinert D, Strnad V, M&uuml;ller R, et al. High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation 2002; 105:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/53\">",
"      Waksman R, Weinberger J. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive. Circulation 2003; 108:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/61/25560/abstract/54\">",
"      Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:e574.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1570 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.102.30.19-3E8788D7EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25560=[""].join("\n");
var outline_f24_61_25560=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Radiation dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Scattering after stenting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Use for in-stent restenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Comparison to drug-eluting stents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Saphenous vein grafts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      De novo stenting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Use for restenosis after PTCA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Use after angioplasty alone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Effect on normal coronary segments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Late thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Restenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prolonged dual antiplatelet therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Edge stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Delayed healing of dissections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Coronary artery spasm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1570\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1570|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/16/24845\" title=\"figure 1\">",
"      Stenting versus PTCA in CAD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/25/36254\" title=\"figure 2\">",
"      Lack of restenosis with sirolimus stent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/46/26349\" title=\"figure 3\">",
"      Outcome intracoronary radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/28/25028\" title=\"figure 4\">",
"      Schematic geographic miss",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=related_link\">",
"      Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=related_link\">",
"      Drug-eluting intracoronary stents: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=related_link\">",
"      Intracoronary stent restenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=related_link\">",
"      Periprocedural complications of percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26538?source=related_link\">",
"      Prevention, presentation, and management of saphenous vein graft stenosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_61_25561="Base of skull anatomy";
var content_f24_61_25561=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60335%7EONC%2F65811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60335%7EONC%2F65811&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Base of skull anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Co. Copyright &copy; 2009 Wolters Kluwer.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Skull sagittal section",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Co. Copyright &copy; 2009 Wolters Kluwer.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25561=[""].join("\n");
var outline_f24_61_25561=null;
var title_f24_61_25562="Uterine morcellation";
var content_f24_61_25562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56759%7EOBGYN%2F70385%7EOBGYN%2F79676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56759%7EOBGYN%2F70385%7EOBGYN%2F79676&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Uterine hemisection technique for uterine morcellation during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 448px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 472px\">",
"   <div class=\"ttl\">",
"    Uterine morcellation during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 452px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Uterine morcellation during vaginal hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25562=[""].join("\n");
var outline_f24_61_25562=null;
var title_f24_61_25563="Chemotherapy induced amenorrhea by age and specific regimen";
var content_f24_61_25563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Incidence of prolonged chemotherapy-induced amenorrhea according to age and type of adjuvant chemotherapy regimen",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Regimen",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Incidence chemotherapy-induced amenorrhea according to age at treatment initiation (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &lt;40 years",
"       </td>",
"       <td class=\"subtitle2\">",
"        &ge;40 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CMF",
"       </td>",
"       <td>",
"        30 to 80",
"       </td>",
"       <td>",
"        60 to 96",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AC",
"       </td>",
"       <td>",
"        13 to 30",
"       </td>",
"       <td>",
"        57 to 63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        FEC/FAC",
"       </td>",
"       <td>",
"        10 to 25",
"       </td>",
"       <td>",
"        80 to 90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AC followed by a single agent taxane",
"       </td>",
"       <td>",
"        15 to 42",
"       </td>",
"       <td>",
"        66 to 77",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AC: doxorubicin plus cyclophosphamide; CMF: cyclophosphamide, methotrexate plus fluorouracil; FAC: fluorouracil, doxorubicin plus cyclophosphamide; FEC: fluorouracil, epirubicin plus cyclophosphamide.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Stearns V, Schneider B, Henry NL, et al. Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 2006; 6:886.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25563=[""].join("\n");
var outline_f24_61_25563=null;
var title_f24_61_25564="Organic psychosis";
var content_f24_61_25564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medical conditions associated with acute psychosis in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Substrate deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypoglycemia*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cerebral hypoxia*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        CNS abnormality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Brain tumor*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Brain abscess*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intracranial injury (head trauma)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CNS infection (meningitis, encephalitis)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stroke*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Interictal psychosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Temporal lobe epilepsy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Landau Kleffner syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        SSPE*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Metabolic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urea cycle defect*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute intermittent porphyria*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Wilson disease*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electrolyte disturbance*",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatic failure*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Uremia*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postpartum psychosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hashimoto thyroiditis (Hashimoto encephalopathy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thyroid storm*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Antiphospholipid syndrome",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous syndrome; SSPE: subacute sclerosing panencephalitis; SLE: systemic lupus erythematosus.",
"     <br>",
"      * Life-threatening.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Causes of cerebral hypoxia include cardiac insufficiency, pulmonary insufficiency, and severe anemia.",
"       <br>",
"        &Delta; Acute psychosis may be seen with hypocalcemia and hypomagnesemia. Hypo- or hypernatremia may cause encephalopathy with delirium.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25564=[""].join("\n");
var outline_f24_61_25564=null;
var title_f24_61_25565="Broad behavior screens I";
var content_f24_61_25565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50139%7EPEDS%2F63959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50139%7EPEDS%2F63959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected broad-band behavioral screens-I",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Test/age range",
"       </td>",
"       <td class=\"subtitle1\">",
"        Purchasing information",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time frame*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Ages and Stages Questionnaire: Social-Emotional (ASQ-SE)",
"         </strong>",
"        </p>",
"        <p>",
"         3 to 66 months",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Paul H. Brookes Publishing, Inc.",
"        </p>",
"        <p>",
"         P.O. Box 10624",
"        </p>",
"        <p>",
"         Baltimore, MD 21285",
"        </p>",
"        <p>",
"         Phone: 800.638.3775",
"        </p>",
"        <p>",
"         <a href=\"file://www.pbrookes.com\" target=\"_blank\">",
"          www.pbrookes.com",
"         </a>",
"        </p>",
"        <p>",
"         Cost of purchasing a specimen set: $149 (includes reproducible questionnaires and users guide).",
"        </p>",
"       </td>",
"       <td>",
"        About 10 minutes (if interview needed)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Brief-Infant-Toddler Social-Emotional Assessment (BITSEA) (2006)",
"         </strong>",
"        </p>",
"        <p>",
"         12 to 36 months",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Pearson Assessments",
"        </p>",
"        <p>",
"         19500 Bulverde Road",
"        </p>",
"        <p>",
"         San Antonio, TX 78259",
"        </p>",
"        <p>",
"         Phone: 800.211.8378",
"        </p>",
"        <p>",
"         <a href=\"file://www.pearsonassessments.com\" target=\"_blank\">",
"          www.pearsonassessments.com",
"         </a>",
"        </p>",
"        <p>",
"         Cost of purchasing a specimen set: $105 (includes manual, 25 BITSEA parent forms, and 25 BITSEA teacher forms).",
"        </p>",
"       </td>",
"       <td>",
"        About 6 minutes (if interview needed)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Conners Rating Scale-Revised",
"         </strong>",
"        </p>",
"        <p>",
"         3 to 17 years",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Pearson Assessments",
"        </p>",
"        <p>",
"         Phone: 800.627.7271",
"        </p>",
"        <p>",
"         <a href=\"file://www.pearsonassessments.com\" target=\"_blank\">",
"          www.pearsonassessments.com",
"         </a>",
"        </p>",
"        <p>",
"         Cost of purchasing a specimen set: $276 (includes manual and 25 quick score forms of various versions).",
"        </p>",
"       </td>",
"       <td>",
"        About 20 minutes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Does not include score time.",
"    </div>",
"    <div class=\"reference\">",
"     Frances Page Glascoe, 2011, Nolensville, TN: PEDSTest.com, LLC, www.pedstest.com. Adapted with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected broad-band behavior screens-II",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Test/age range",
"       </td>",
"       <td class=\"subtitle1\">",
"        Purchasing information",
"       </td>",
"       <td class=\"subtitle1\">",
"        Time frame*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Eyberg Child Behavior Inventory/Sutter-Eyberg Student Behavior Inventory-Revised (ECBI/SESBI-R)",
"         </strong>",
"        </p>",
"        <p>",
"         2 to 16",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Psychological Assessment Resources",
"        </p>",
"        <p>",
"         P.O. Box 998",
"        </p>",
"        <p>",
"         Odessa, FL 33556",
"        </p>",
"        <p>",
"         Phone: 800.331.8378",
"        </p>",
"        <p>",
"         <a href=\"file://www.parinc.com\" target=\"_blank\">",
"          www.parinc.com",
"         </a>",
"        </p>",
"        <p>",
"         Cost of purchasing a specimen set: $120 (includes professional manual, 50 ECBI and 50 SESBI-R test sheets).",
"        </p>",
"       </td>",
"       <td>",
"        About 5 minutes (if interview needed)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Parents' Evaluations of Developmental Status (PEDS) (2010)",
"         </strong>",
"        </p>",
"        <p>",
"         Birth to 8 years",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         PEDS",
"         <em>",
"          Test",
"         </em>",
"         .com, LLC",
"        </p>",
"        <p>",
"         1013 Austin Court",
"        </p>",
"        <p>",
"         Nolensville, TN 37135",
"        </p>",
"        <p>",
"         Phone: 615.776.4121",
"        </p>",
"        <p>",
"         Fax: 615.776.4119",
"        </p>",
"        <p>",
"         <a href=\"file://www.pedstest.com\" target=\"_blank\">",
"          www.pedstest.com",
"         </a>",
"        </p>",
"        <p>",
"         Cost of purchasing a specimen set: $30 (includes 50 response forms, 50 score and interpretation forms, and one brief administration and scoring guide).",
"        </p>",
"       </td>",
"       <td>",
"        About 2 minutes",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <p>",
"         <strong>",
"          Pediatric Symptom Checklist (PSC) and Pictorial Pediatric Symptom Checklist",
"         </strong>",
"        </p>",
"        <p>",
"         4 to 16 years",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Can be downloaded for free at:",
"        </p>",
"        <p>",
"         <a href=\"file://www2.massgeneral.org/allpsych/psc/psc_forms.htm\" target=\"_blank\">",
"          www2.massgeneral.org/allpsych/psc/psc_forms.htm",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        About 3 minutes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Does not include score time.",
"    </div>",
"    <div class=\"reference\">",
"     Frances Page Glascoe, 2011, Nolensville, TN: PEDSTest.com, LLC, www.pedstest.com. Adapted with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25565=[""].join("\n");
var outline_f24_61_25565=null;
var title_f24_61_25566="Outcome subgroups vesnarinone";
var content_f24_61_25566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vesnarinone increases mortality in patients with heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 409px; height: 356px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Analysis of hazard ratios and 95 percent confidence intervals shows that death from any cause is increased in all subgroups of patients assigned to receive 60 mg of vesnarinone per day as compared with those assigned to receive placebo. The dotted line (hazard ratio, 1.0) indicates the risk of death in the placebo group.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Cohn JN, Goldstein JO, Greenberg BH, et al. N Engl J Med 1998; 339:1810.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25566=[""].join("\n");
var outline_f24_61_25566=null;
var title_f24_61_25567="Normal ileostomy stoma";
var content_f24_61_25567=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F70992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F70992&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Healthy-appearing \"bud\" ileostomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 183px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ideal ileostomy stoma with a well-protruding \"bud\". The stoma should be lying on a flat 3 to 4 inches of abdominal skin within easy reach of the patient",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey B Matthews, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_61_25567=[""].join("\n");
var outline_f24_61_25567=null;
